Bictegravir Impurity 18

Basic Information

View in Editor

CAS Number

1335210-23-5

Molecular Formula

C13H17NO8

Molecular Weight

315.28 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Esters

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Basic Physical Properties

Boiling Point

474.1±45.0°C at 760 mmHg

SMILES

View in Editor

COC(Cn1cc(C(=O)O)c(=O)c(c1C(=O)OC)OC)OC

InChI

InChI=1S/C13H17NO8/c1-19-8(20-2)6-14-5-7(12(16)17)10(15)11(21-3)9(14)13(18)22-4/h5,8H,6H2,1-4H3,(H,16,17)

InChIKey

XAXGEECGULRZGN-UHFFFAOYSA-N

LogP

-0.0394000000000001

Topological Polar Surface Area

113.29 Å²

Hydrogen Bond Donor/Acceptor

1 / 9

Complexity

532

Safety Information

View Safety Information

Hazard Statement

H302 Harmful if swallowed
Acute toxicity, oral

H315 Causes skin irritation
Skin corrosion/irritation

H319 Causes serious eye irritation
Serious eye damage/eye irritation

H335 May cause respiratory irritation
Specific target organ toxicity, single exposure; Respiratory tract irritation

Synonyms & References

English

1-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid
2,5-Pyridinedicarboxylic acid, 1-(2,2-dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo-, 2-methyl ester
Dolutegravir intermediate-1
1-(2,2-Dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo-2,5-pyridinedicarboxylic acid 2-methyl ester
Dulotegravir Me-N-4
XAXGEECGULRZGN-UHFFFAOYSA-N
BCP15319
1-[2,2-Bis(methyloxy)ethyl]-5-(methyloxy)-6-[(methyloxy)carbonyl]-4-oxo-1,4-dihydro-3-pyridinecarboxylic acid
SY103843
AK342700
HY-1

MDL Number

MFCD28978322

FAQ

What regulatory guidelines apply to Bictegravir Impurity 18 (CAS: 1335210-23-5)?

Bictegravir Impurity 18 (CAS: 1335210-23-5) must comply with GHS classification for hazardous substances, REACH regulations in the EU, and FDA/EPA requirements for pharmaceutical and chemical products. Specific regulations will vary based on its intended use and application.

Are there alternatives to Bictegravir Impurity 18 (CAS: 1335210-23-5) in synthesis?

Alternatives to Bictegravir Impurity 18 (CAS: 1335210-23-5) in synthesis include using other impurities or analogs, such as structural isomers or alternative reagents that may offer similar properties. However, specific alternatives depend on the synthesis pathway and desired chemical outcome.

What is the market or research trend for Bictegravir Impurity 18 (CAS: 1335210-23-5)?

The market and research trends for Bictegravir Impurity 18 (CAS: 1335210-23-5) are closely tied to advancements in HIV treatment and drug development. There is significant interest in understanding and controlling impurities to ensure drug safety and efficacy. Research is focusing on improving synthesis methods and purity standards.

How should waste containing Bictegravir Impurity 18 (CAS: 1335210-23-5) be handled?

Waste containing Bictegravir Impurity 18 (CAS: 1335210-23-5) should be managed according to local and national regulations. Typically, it should be collected in appropriate containers, labeled, and transported to a licensed facility for incineration or professional waste disposal. Environmental protection measures, such as neutralization and precipitation, may be necessary to prevent environmental contamination.